Skip to content

Magnetic resonance spectroscopy study of cerebral ischemia-reperfusion

Magnetic resonance spectroscopy study of cerebral ischemia-reperfusion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066537
Enrollment
Unknown
Registered
2022-12-08
Start date
2022-12-12
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Sponsors

Weihai Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. The time from onset to randomization is within 24 hours; 3. According to clinical symptoms or imaging examination, it was preliminarily diagnosed as anterior circulation great vessel occlusive stroke; 4. NIHSS score >5; 5. Score of ASPECTS >=5 points; 6. CTA/ MRA/ DSA confirmed occlusion of intracranial segments of internal carotid artery and M1 and M2 segments of middle cerebral artery, and decided to perform endovascular therapy; 7. Written informed consent signed by patient or family member.

Exclusion criteria

Exclusion criteria: 1. Skull computed tomography (CT) or magnetic resonance imaging (MRI) confirmed intracranial hemorrhage; 2. Patients with unvascularized blood vessels after dissolution/thrombectomy, failure of reperfusion or bleeding transformation after reperfusion resulted in serious condition and were not suitable for MRI outside; 3. mRS Score >=2 before onset; 4. Pregnant patients, positive pregnancy test and lactating patients; 5. Patients with coagulation disorders and metabolic diseases; 6. Patients with chronic hemodialysis and severe renal insufficiency (glomerular filtration rate 220µmol/L (2.5mg/dl)); 7. Patients with liver insufficiency; 8. Patients who do not comply with study procedures due to alcoholism, drug dependence, non-compliance with medical advice or other reasons, and patients who are not expected to complete follow-up; 9. Brain tumors and tumors of other tissues and organs of the body with space occupying effect on imaging; 10. Patients with systemic infectious diseases, AIDS and other infectious diseases; 11. Patients suffering from mental illness and mental disorders.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale (MRS) Score;National Institute of Health Stroke Scale Score;

Secondary

MeasureTime frame
serum lactate;serum glucose;

Countries

China

Contacts

Public ContactWang Pengfei/Xiong Xiaoyi

Weihai Municipal Hospital/ Chengdu University of Traditional Chinese Medicine

xiongxy_89@163.com+86 18008039361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026